(NASDAQ: LUCD) Lucid Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 56.59%.
Lucid Diagnostics's earnings in 2025 is -$70,935,000.On average, 1 Wall Street analyst forecast LUCD's earnings for 2025 to be -$40,931,413, with the lowest LUCD earnings forecast at -$40,931,413, and the highest LUCD earnings forecast at -$40,931,413.
In 2026, LUCD is forecast to generate -$32,745,130 in earnings, with the lowest earnings forecast at -$32,745,130 and the highest earnings forecast at -$32,745,130.